TIFFANY ROUSE: Open Payments
NPI 1760652283 · BLAIRSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 21 payments from 16 companies in 2025. Trend: 2023 $396 · 2024 $467 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $58 |
| ABBVIE INC. | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| ACADIA Pharmaceuticals Inc | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, ELIQUIS, XIFAXAN, NUPLAZID, INSPIRE, VERQUVO, Ozempic, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
